Literature DB >> 2707573

Proline and proline derivatives as anticonvulsants.

S Sarhan1, N Seiler.   

Abstract

1. The anticonvulsant properties of L-proline, of proline derivatives (trans-4-hydroxy-L-proline, cis-4-hydroxy-D-proline, 3,4-dehydro-D,L-proline) and of D- and L-pipecolic acid were studied alone and in combination with vigabatrin (R/S-4-aminohex-5-enoic acid). 3-Mercaptopropionic acid and pentylenetetrazol-induced convulsions in mice were used as animal models of epilepsy. 2. Proline and proline derivatives are weak anticonvulsants if given alone in doses up to 10 mmol/kg, however, they are capable of potentiating the anticonvulsant effects of vigabatrin, in a manner similar to that reported previously for glycine, and some glycine derivatives. Among the compounds tested, trans-4-hydroxy-L-proline was the most potent anticonvulsant in combination with the indirect GABA agonist vigabatrin. 3. A potential explanation for the synergistic anticonvulsant effect of the combination of the GABA agonist and proline is the presumed role of proline as inhibitory neurotransmitter, and/or its glutamate antagonistic effects. 4. The current study points out the lack of basic knowledge on the neurochemistry and pharmacology of proline and hydroxyproline.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707573     DOI: 10.1016/0306-3623(89)90060-8

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  2 in total

Review 1.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

2.  A Proline Derivative-Enriched Fraction from Sideroxylon obtusifolium Protects the Hippocampus from Intracerebroventricular Pilocarpine-Induced Injury Associated with Status Epilepticus in Mice.

Authors:  Pedro Everson Alexandre de Aquino; Jéssica Rabelo Bezerra; Tyciane de Souza Nascimento; Juliete Tavares; Ítalo Rosal Lustosa; Adriano José Maia Chaves Filho; Melina Mottin; Danielle Macêdo Gaspar; Geanne Matos de Andrade; Kelly Rose Tavares Neves; Giuseppe Biagini; Edilberto Rocha Silveira; Glauce Socorro de Barros Viana
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.